APO Research
Talk to an analyst

APO RESEARCH · REPORT

Protein G Sepharose

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Protein G Sepharose Market Outlook and Growth Opportunities 2026

8 January 2026194 pages

Choose your research edition.

Industry ResearchProtein G Sepharose Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Protein G Sepharose Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Protein G Sepharose Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Protein G Sepharose Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Protein G Sepharose Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Protein G Sepharose market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Protein G Sepharose market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Protein G Sepharose market include Merck, Thermo Fisher Scientific, Abcam, Calibre Scientific, Chondrex, SERVA Electrophoresis, Neo Biotech, Rockland and M&S TechnoSystems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Protein G Sepharose market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Protein G Sepharose and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Protein G Sepharose sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Protein G Sepharose market size, projected growth trends, production technologies, key applications, and end-use industries.

Protein G Sepharose Segment by Company

Merck

Thermo Fisher Scientific

Abcam

Calibre Scientific

Chondrex

SERVA Electrophoresis

Neo Biotech

Rockland

M&S TechnoSystems

MedChemExpress

Yeasen

TargetMol

bersee

Heyuan Liji

Fujian Herui biotechnology

Protein G Sepharose Segment by Type

Covalent Coupling Type

Non-covalent Adsorption Type

Protein G Sepharose Segment by Application

Antibody Purification

Biopharmaceutical and Vaccine Research and Development

Diagnostic Reagent Development

Proteomics Research

Others

Protein G Sepharose Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Protein G Sepharose status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Protein G Sepharose market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Protein G Sepharose significant trends, drivers, influence factors in global and regions.

6. To analyze Protein G Sepharose competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein G Sepharose market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Protein G Sepharose and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein G Sepharose.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Protein G Sepharose market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Protein G Sepharose industry.

Chapter 3: Detailed analysis of Protein G Sepharose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Protein G Sepharose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Protein G Sepharose in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Protein G Sepharose Industry Trends Table 2. Protein G Sepharose Industry Drivers Table 3. Protein G Sepharose Industry Opportunities and Challenges Table 4. Protein G Sepharose Industry Restraints Table 5. Global Protein G Sepharose Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Protein G Sepharose Revenue Share by Company (2021-2026) Table 7. Global Protein G Sepharose Sales Volume by Company (k L) & (2021-2026) Table 8. Global Protein G Sepharose Sales Volume Share by Company (2021-2026) Table 9. Global Protein G Sepharose Average Price (USD/L) of Company (2021-2026) Table 10. Global Protein G Sepharose Company Ranking, (2024-2026) & (USD Million) Table 11. Global Protein G Sepharose Key Company Manufacturing Base & Headquarters Table 12. Global Protein G Sepharose Company, Product Type & Application Table 13. Global Protein G Sepharose Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Protein G Sepharose by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Covalent Coupling Type Table 18. Significant Companies of Non-covalent Adsorption Type Table 19. Global Protein G Sepharose Sales Volume by Type 2021 VS 2025 VS 2032 (k L) Table 20. Global Protein G Sepharose Sales Volume by Type (2021-2026) & (k L) Table 21. Global Protein G Sepharose Sales Volume by Type (2027-2032) & (k L) Table 22. Global Protein G Sepharose Sales Volume Share by Type (2021-2026) Table 23. Global Protein G Sepharose Sales Volume Share by Type (2027-2032) Table 24. Global Protein G Sepharose Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Protein G Sepharose Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Protein G Sepharose Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Protein G Sepharose Sales Value Share by Type (2021-2026) Table 28. Global Protein G Sepharose Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Antibody Purification Table 30. Significant Companies of Biopharmaceutical and Vaccine Research and Development Table 31. Significant Companies of Diagnostic Reagent Development Table 32. Significant Companies of Proteomics Research Table 33. Significant Companies of Others Table 34. Global Protein G Sepharose Sales Volume by Application 2021 VS 2025 VS 2032 (k L) Table 35. Global Protein G Sepharose Sales Volume by Application (2021-2026) & (k L) Table 36. Global Protein G Sepharose Sales Volume by Application (2027-2032) & (k L) Table 37. Global Protein G Sepharose Sales Volume Share by Application (2021-2026) Table 38. Global Protein G Sepharose Sales Volume Share by Application (2027-2032) Table 39. Global Protein G Sepharose Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Protein G Sepharose Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Protein G Sepharose Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Protein G Sepharose Sales Value Share by Application (2021-2026) Table 43. Global Protein G Sepharose Sales Value Share by Application (2027-2032) Table 44. Global Protein G Sepharose Sales by Region: 2021 VS 2025 VS 2032 (k L) Table 45. Global Protein G Sepharose Sales by Region (2021-2026) & (k L) Table 46. Global Protein G Sepharose Sales Market Share by Region (2021-2026) Table 47. Global Protein G Sepharose Sales by Region (2027-2032) & (k L) Table 48. Global Protein G Sepharose Sales Market Share by Region (2027-2032) Table 49. Global Protein G Sepharose Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Protein G Sepharose Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Protein G Sepharose Sales Value Share by Region (2021-2026) Table 52. Global Protein G Sepharose Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Protein G Sepharose Sales Value Share by Region (2027-2032) Table 54. Global Protein G Sepharose Market Average Price (USD/L) by Region (2021-2026) Table 55. Global Protein G Sepharose Market Average Price (USD/L) by Region (2027-2032) Table 56. Global Protein G Sepharose Sales by Country: 2021 VS 2025 VS 2032 (k L) Table 57. Global Protein G Sepharose Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Protein G Sepharose Sales by Country (2021-2026) & (k L) Table 59. Global Protein G Sepharose Sales Market Share by Country (2021-2026) Table 60. Global Protein G Sepharose Sales by Country (2027-2032) & (k L) Table 61. Global Protein G Sepharose Sales Market Share by Country (2027-2032) Table 62. Global Protein G Sepharose Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Protein G Sepharose Sales Value Market Share by Country (2021-2026) Table 64. Global Protein G Sepharose Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Protein G Sepharose Sales Value Market Share by Country (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 69. Merck Protein G Sepharose Product Portfolio Table 70. Merck Recent Development Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Protein G Sepharose Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Abcam Company Information Table 77. Abcam Business Overview Table 78. Abcam Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 79. Abcam Protein G Sepharose Product Portfolio Table 80. Abcam Recent Development Table 81. Calibre Scientific Company Information Table 82. Calibre Scientific Business Overview Table 83. Calibre Scientific Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 84. Calibre Scientific Protein G Sepharose Product Portfolio Table 85. Calibre Scientific Recent Development Table 86. Chondrex Company Information Table 87. Chondrex Business Overview Table 88. Chondrex Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 89. Chondrex Protein G Sepharose Product Portfolio Table 90. Chondrex Recent Development Table 91. SERVA Electrophoresis Company Information Table 92. SERVA Electrophoresis Business Overview Table 93. SERVA Electrophoresis Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 94. SERVA Electrophoresis Protein G Sepharose Product Portfolio Table 95. SERVA Electrophoresis Recent Development Table 96. Neo Biotech Company Information Table 97. Neo Biotech Business Overview Table 98. Neo Biotech Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 99. Neo Biotech Protein G Sepharose Product Portfolio Table 100. Neo Biotech Recent Development Table 101. Rockland Company Information Table 102. Rockland Business Overview Table 103. Rockland Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 104. Rockland Protein G Sepharose Product Portfolio Table 105. Rockland Recent Development Table 106. M&S TechnoSystems Company Information Table 107. M&S TechnoSystems Business Overview Table 108. M&S TechnoSystems Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 109. M&S TechnoSystems Protein G Sepharose Product Portfolio Table 110. M&S TechnoSystems Recent Development Table 111. MedChemExpress Company Information Table 112. MedChemExpress Business Overview Table 113. MedChemExpress Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 114. MedChemExpress Protein G Sepharose Product Portfolio Table 115. MedChemExpress Recent Development Table 116. Yeasen Company Information Table 117. Yeasen Business Overview Table 118. Yeasen Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 119. Yeasen Protein G Sepharose Product Portfolio Table 120. Yeasen Recent Development Table 121. TargetMol Company Information Table 122. TargetMol Business Overview Table 123. TargetMol Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 124. TargetMol Protein G Sepharose Product Portfolio Table 125. TargetMol Recent Development Table 126. bersee Company Information Table 127. bersee Business Overview Table 128. bersee Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 129. bersee Protein G Sepharose Product Portfolio Table 130. bersee Recent Development Table 131. Heyuan Liji Company Information Table 132. Heyuan Liji Business Overview Table 133. Heyuan Liji Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 134. Heyuan Liji Protein G Sepharose Product Portfolio Table 135. Heyuan Liji Recent Development Table 136. Fujian Herui biotechnology Company Information Table 137. Fujian Herui biotechnology Business Overview Table 138. Fujian Herui biotechnology Protein G Sepharose Sales (k L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 139. Fujian Herui biotechnology Protein G Sepharose Product Portfolio Table 140. Fujian Herui biotechnology Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Protein G Sepharose Distributors List Table 144. Protein G Sepharose Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Protein G Sepharose Product Image Figure 2. Global Protein G Sepharose Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 4. Global Protein G Sepharose Sales (2021-2032) & (k L) Figure 5. Global Protein G Sepharose Sales Average Price (USD/L) & (2021-2032) Figure 6. Global Protein G Sepharose Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Covalent Coupling Type Image Figure 10. Non-covalent Adsorption Type Image Figure 11. Global Protein G Sepharose Sales Volume by Type (2021 VS 2025 VS 2032) & (k L) Figure 12. Global Protein G Sepharose Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Protein G Sepharose Sales Volume Share by Type (2021-2032) Figure 14. Global Protein G Sepharose Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Protein G Sepharose Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Protein G Sepharose Sales Value Share by Type (2021-2032) Figure 17. Antibody Purification Image Figure 18. Biopharmaceutical and Vaccine Research and Development Image Figure 19. Diagnostic Reagent Development Image Figure 20. Proteomics Research Image Figure 21. Others Image Figure 22. Global Protein G Sepharose Sales Volume by Application (2021 VS 2025 VS 2032) & (k L) Figure 23. Global Protein G Sepharose Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Protein G Sepharose Sales Volume Share by Application (2021-2032) Figure 25. Global Protein G Sepharose Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Protein G Sepharose Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Protein G Sepharose Sales Value Share by Application (2021-2032) Figure 28. Global Protein G Sepharose Sales by Region: 2021 VS 2025 VS 2032 (k L) Figure 29. Global Protein G Sepharose Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Protein G Sepharose Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Protein G Sepharose Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 33. North America Protein G Sepharose Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Protein G Sepharose Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Protein G Sepharose Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 39. South America Protein G Sepharose Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Protein G Sepharose Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Protein G Sepharose Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Protein G Sepharose Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Protein G Sepharose Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Protein G Sepharose Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Protein G Sepharose Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Protein G Sepharose Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Covalent Coupling Type
  • Non-covalent Adsorption Type
Applications
  • Antibody Purification
  • Biopharmaceutical and Vaccine Research and Development
  • Diagnostic Reagent Development
  • Proteomics Research
  • Others
Companies covered
  • Merck
  • Thermo Fisher Scientific
  • Abcam
  • Calibre Scientific
  • Chondrex
  • SERVA Electrophoresis
  • Neo Biotech
  • Rockland
  • M&S TechnoSystems
  • MedChemExpress
  • Yeasen
  • TargetMol
  • bersee
  • Heyuan Liji
  • Fujian Herui biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Protein G Sepharose Sales Value (2021-2032)
  4. 1.2.2 Global Protein G Sepharose Sales Volume (2021-2032)
  5. 1.2.3 Global Protein G Sepharose Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Protein G Sepharose Market Dynamics
  1. 2.1 Protein G Sepharose Industry Trends
  2. 2.2 Protein G Sepharose Industry Drivers
  3. 2.3 Protein G Sepharose Industry Opportunities and Challenges
  4. 2.4 Protein G Sepharose Industry Restraints
3 Protein G Sepharose Market by Company
  1. 3.1 Global Protein G Sepharose Company Revenue Ranking in 2025
  2. 3.2 Global Protein G Sepharose Revenue by Company (2021-2026)
  3. 3.3 Global Protein G Sepharose Sales Volume by Company (2021-2026)
  4. 3.4 Global Protein G Sepharose Average Price by Company (2021-2026)
  5. 3.5 Global Protein G Sepharose Company Ranking (2024-2026)
  6. 3.6 Global Protein G Sepharose Company Manufacturing Base and Headquarters
  7. 3.7 Global Protein G Sepharose Company Product Type and Application
  8. 3.8 Global Protein G Sepharose Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Protein G Sepharose Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Protein G Sepharose Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Protein G Sepharose Market by Type
  1. 4.1 Protein G Sepharose Type Introduction
  2. 4.1.1 Covalent Coupling Type
  3. 4.1.2 Non-covalent Adsorption Type
  4. 4.2 Global Protein G Sepharose Sales Volume by Type
  5. 4.2.1 Global Protein G Sepharose Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Protein G Sepharose Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Protein G Sepharose Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Protein G Sepharose Sales Value by Type
  9. 4.3.1 Global Protein G Sepharose Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Protein G Sepharose Sales Value by Type (2021-2032)
  11. 4.3.3 Global Protein G Sepharose Sales Value Share by Type (2021-2032)
5 Protein G Sepharose Market by Application
  1. 5.1 Protein G Sepharose Application Introduction
  2. 5.1.1 Antibody Purification
  3. 5.1.2 Biopharmaceutical and Vaccine Research and Development
  4. 5.1.3 Diagnostic Reagent Development
  5. 5.1.4 Proteomics Research
  6. 5.1.5 Others
  7. 5.2 Global Protein G Sepharose Sales Volume by Application
  8. 5.2.1 Global Protein G Sepharose Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Protein G Sepharose Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Protein G Sepharose Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Protein G Sepharose Sales Value by Application
  12. 5.3.1 Global Protein G Sepharose Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Protein G Sepharose Sales Value by Application (2021-2032)
  14. 5.3.3 Global Protein G Sepharose Sales Value Share by Application (2021-2032)
6 Protein G Sepharose Regional Sales and Value Analysis
  1. 6.1 Global Protein G Sepharose Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Protein G Sepharose Sales by Region (2021-2032)
  3. 6.2.1 Global Protein G Sepharose Sales by Region: 2021-2026
  4. 6.2.2 Global Protein G Sepharose Sales by Region (2027-2032)
  5. 6.3 Global Protein G Sepharose Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Protein G Sepharose Sales Value by Region (2021-2032)
  7. 6.4.1 Global Protein G Sepharose Sales Value by Region: 2021-2026
  8. 6.4.2 Global Protein G Sepharose Sales Value by Region (2027-2032)
  9. 6.5 Global Protein G Sepharose Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Protein G Sepharose Sales Value (2021-2032)
  12. 6.6.2 North America Protein G Sepharose Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Protein G Sepharose Sales Value (2021-2032)
  15. 6.7.2 Europe Protein G Sepharose Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Protein G Sepharose Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Protein G Sepharose Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Protein G Sepharose Sales Value (2021-2032)
  21. 6.9.2 South America Protein G Sepharose Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Protein G Sepharose Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Protein G Sepharose Sales Value Share by Country, 2025 VS 2032
7 Protein G Sepharose Country-level Sales and Value Analysis
  1. 7.1 Global Protein G Sepharose Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Protein G Sepharose Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Protein G Sepharose Sales by Country (2021-2032)
  4. 7.3.1 Global Protein G Sepharose Sales by Country (2021-2026)
  5. 7.3.2 Global Protein G Sepharose Sales by Country (2027-2032)
  6. 7.4 Global Protein G Sepharose Sales Value by Country (2021-2032)
  7. 7.4.1 Global Protein G Sepharose Sales Value by Country (2021-2026)
  8. 7.4.2 Global Protein G Sepharose Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Protein G Sepharose Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Protein G Sepharose Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Protein G Sepharose Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Protein G Sepharose Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Protein G Sepharose Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Protein G Sepharose Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Protein G Sepharose Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Protein G Sepharose Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Protein G Sepharose Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Protein G Sepharose Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Protein G Sepharose Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Protein G Sepharose Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Protein G Sepharose Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Protein G Sepharose Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Protein G Sepharose Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Protein G Sepharose Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Protein G Sepharose Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Protein G Sepharose Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Protein G Sepharose Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Protein G Sepharose Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Protein G Sepharose Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Protein G Sepharose Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Protein G Sepharose Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Protein G Sepharose Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Protein G Sepharose Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Protein G Sepharose Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Protein G Sepharose Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Protein G Sepharose Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Protein G Sepharose Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Protein G Sepharose Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Protein G Sepharose Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Protein G Sepharose Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Abcam
  14. 8.3.1 Abcam Company Information
  15. 8.3.2 Abcam Business Overview
  16. 8.3.3 Abcam Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Abcam Protein G Sepharose Product Portfolio
  18. 8.3.5 Abcam Recent Developments
  19. 8.4 Calibre Scientific
  20. 8.4.1 Calibre Scientific Company Information
  21. 8.4.2 Calibre Scientific Business Overview
  22. 8.4.3 Calibre Scientific Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Calibre Scientific Protein G Sepharose Product Portfolio
  24. 8.4.5 Calibre Scientific Recent Developments
  25. 8.5 Chondrex
  26. 8.5.1 Chondrex Company Information
  27. 8.5.2 Chondrex Business Overview
  28. 8.5.3 Chondrex Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chondrex Protein G Sepharose Product Portfolio
  30. 8.5.5 Chondrex Recent Developments
  31. 8.6 SERVA Electrophoresis
  32. 8.6.1 SERVA Electrophoresis Company Information
  33. 8.6.2 SERVA Electrophoresis Business Overview
  34. 8.6.3 SERVA Electrophoresis Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SERVA Electrophoresis Protein G Sepharose Product Portfolio
  36. 8.6.5 SERVA Electrophoresis Recent Developments
  37. 8.7 Neo Biotech
  38. 8.7.1 Neo Biotech Company Information
  39. 8.7.2 Neo Biotech Business Overview
  40. 8.7.3 Neo Biotech Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Neo Biotech Protein G Sepharose Product Portfolio
  42. 8.7.5 Neo Biotech Recent Developments
  43. 8.8 Rockland
  44. 8.8.1 Rockland Company Information
  45. 8.8.2 Rockland Business Overview
  46. 8.8.3 Rockland Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rockland Protein G Sepharose Product Portfolio
  48. 8.8.5 Rockland Recent Developments
  49. 8.9 M&S TechnoSystems
  50. 8.9.1 M&S TechnoSystems Company Information
  51. 8.9.2 M&S TechnoSystems Business Overview
  52. 8.9.3 M&S TechnoSystems Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 M&S TechnoSystems Protein G Sepharose Product Portfolio
  54. 8.9.5 M&S TechnoSystems Recent Developments
  55. 8.10 MedChemExpress
  56. 8.10.1 MedChemExpress Company Information
  57. 8.10.2 MedChemExpress Business Overview
  58. 8.10.3 MedChemExpress Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MedChemExpress Protein G Sepharose Product Portfolio
  60. 8.10.5 MedChemExpress Recent Developments
  61. 8.11 Yeasen
  62. 8.11.1 Yeasen Company Information
  63. 8.11.2 Yeasen Business Overview
  64. 8.11.3 Yeasen Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Yeasen Protein G Sepharose Product Portfolio
  66. 8.11.5 Yeasen Recent Developments
  67. 8.12 TargetMol
  68. 8.12.1 TargetMol Company Information
  69. 8.12.2 TargetMol Business Overview
  70. 8.12.3 TargetMol Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 TargetMol Protein G Sepharose Product Portfolio
  72. 8.12.5 TargetMol Recent Developments
  73. 8.13 bersee
  74. 8.13.1 bersee Company Information
  75. 8.13.2 bersee Business Overview
  76. 8.13.3 bersee Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 bersee Protein G Sepharose Product Portfolio
  78. 8.13.5 bersee Recent Developments
  79. 8.14 Heyuan Liji
  80. 8.14.1 Heyuan Liji Company Information
  81. 8.14.2 Heyuan Liji Business Overview
  82. 8.14.3 Heyuan Liji Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Heyuan Liji Protein G Sepharose Product Portfolio
  84. 8.14.5 Heyuan Liji Recent Developments
  85. 8.15 Fujian Herui biotechnology
  86. 8.15.1 Fujian Herui biotechnology Company Information
  87. 8.15.2 Fujian Herui biotechnology Business Overview
  88. 8.15.3 Fujian Herui biotechnology Protein G Sepharose Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Fujian Herui biotechnology Protein G Sepharose Product Portfolio
  90. 8.15.5 Fujian Herui biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Protein G Sepharose Value Chain Analysis
  2. 9.1.1 Protein G Sepharose Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Protein G Sepharose Sales Mode & Process
  6. 9.2 Protein G Sepharose Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Protein G Sepharose Distributors
  9. 9.2.3 Protein G Sepharose Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst